1. Home
  2. RVSB vs TTRX Comparison

RVSB vs TTRX Comparison

Compare RVSB & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Riverview Bancorp Inc

RVSB

Riverview Bancorp Inc

HOLD

Current Price

$5.62

Market Cap

117.2M

Sector

Finance

ML Signal

HOLD

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$3.42

Market Cap

116.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RVSB
TTRX
Founded
1923
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
117.2M
116.0M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
RVSB
TTRX
Price
$5.62
$3.42
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$7.00
$8.00
AVG Volume (30 Days)
36.7K
20.8K
Earning Date
04-28-2026
03-31-2026
Dividend Yield
1.38%
N/A
EPS Growth
N/A
N/A
EPS
0.18
N/A
Revenue
N/A
N/A
Revenue This Year
$11.67
N/A
Revenue Next Year
$14.55
N/A
P/E Ratio
$32.28
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.74
$2.57
52 Week High
$6.59
$5.98

Technical Indicators

Market Signals
Indicator
RVSB
TTRX
Relative Strength Index (RSI) 59.20 51.33
Support Level $5.29 $2.98
Resistance Level $5.77 $3.73
Average True Range (ATR) 0.16 0.24
MACD 0.03 0.03
Stochastic Oscillator 70.54 77.40

Price Performance

Historical Comparison
RVSB
TTRX

About RVSB Riverview Bancorp Inc

Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology company focused on developing pharmaceutical and medical device products for dermatology, wound care, and infectious disease. The company's proprietary platform technology, called PermaFusion, enhances drug performance by improving the stability and bioavailability of active pharmaceutical ingredients, which allows for reduced doses and fewer side effects. Its primary development programs target skin conditions such as moderate to severe eczema and onychomycosis.

Share on Social Networks: